High Risk Cancer (DBCOND0141914)

Identifiers

Synonyms
High-Risk Cancer

Associated Data

Indicated Drugs and Targets
Not Available
Clinical Trials
IdentifierTitleDrug(s)PurposePhaseStatus
NCT06041490
Adjuvant Therapy for High-risk Hepatocellular Carcinoma Post Liver Transplantationprevention2not_yet_recruiting
NCT05557487
Taiwan Real-world LDCT Screening Behavior and Outcome Research for High Risk Subjects Based on Health Promotion AdministrationNo drug interventionsNot AvailableNot Availablerecruiting
NCT04947098
Prevent Cancer- GreenvilleNo drug interventionsNot AvailableNot Availablerecruiting
NCT04217356
Study of Stem Cell Transplant vs. Non-Transplant Therapies in High-Risk MyelofibrosisNot AvailableNot Availablerecruiting
NCT06046625
Needs and Preferences of Patients With Head-neck Cutaneous SCCNo drug interventionsNot AvailableNot Availableactive_not_recruiting
NCT04740866
Adjuvant Radiotherapy Versus Observation After Radical Cystectomy in High Risk Urothelial Bladder CancerNo drug interventionstreatmentNot Availableunknown_status
NCT05498272
Study of Neoadjuvant PARP Inhibition Followed by Radical Prostatectomy in Patients With Unfavorable Intermediate-Risk or High-Risk Prostate Cancer With BRCA1/2 Gene Alterationstreatment2recruiting
NCT06327568
Anal Cancer and/or Precancer Screening: Performance Analysis of the BD Onclarity™ HPV Assay on Anal SpecimensNo drug interventionsNot AvailableNot Availablerecruiting
NCT01941550
Neoadjuvant Chemotherapy With Cabazitaxeltreatment2terminated
NCT04334993
Pediatric-type Therapy With Pre-transplant Blinatumomab for HR Patients - Phase II Studytreatment2recruiting
NCT01827137
WT1 Analog Peptide Vaccine in Patients With Multiple Myeloma Following Autologous Stem Cell TransplantationtreatmentNot Availableunknown_status
NCT05254899
Anti-PD-1 Antibody and P-GEMOX Chemotherapy Combined With Radiotherapy in High-risk Early-Stage ENKTLtreatment2recruiting
NCT03343249
Adjunctive Smart Phone Based Smoking Cessation TreatmentNo drug interventionsotherNot Availablecompleted
NCT03978663
Three Fraction Radiation to Induce Immuno-Oncologic ResponseNo drug interventionstreatmentNot Availablerecruiting
NCT05120622
Trial of Local Cystoscopic Injection of Tremelimumab Plus Systemic Durvalumab for High Risk Non-Muscle Invasive Bladder Cancertreatment1 / 2withdrawn
NCT02308280
Nonmyeloablative Allogeneic Stem Cell Transplant Followed by Bortezomib in High-risk Multiple Myeloma Patientstreatment2completed
NCT05482880
Decisional Conflicts, Health-related QoL and Satisfaction With Care in High-risk cSCC in the Head-neck RegionNo drug interventionsNot AvailableNot Availablerecruiting
NCT04905329
A Multicenter Prospective Post-registration Study of Empegfilgrastim to Evaluate Safety and Efficacy in Special Cancer PopulationsNot AvailableNot Availableunknown_status
NCT01479192
Fenretinide in Healthy Young Women at Genetic and Familial Riskprevention3terminated
NCT06277050
Maintenance Therapy With Toripalimab and Capecitabine Versus Capecitabine Alone in High-risk Nasopharyngeal Carcinomatreatment3recruiting
NCT06020443
Adherence to Lung Cancer Screening by Low-dose Thoracic CT in Haut-Rhin Department, France.No drug interventionsdiagnosticNot Availablerecruiting
NCT06576232
Standalone Observational Study Assessing the Performance of an AI/ML Tech-based SaMD on Chest LDCT Images (REALITY)No drug interventionsNot AvailableNot Availablecompleted
NCT05013216
Mutant KRAS -Targeted Long Peptide Vaccine for Patients at High Risk of Developing Pancreatic Cancerprevention1recruiting